Floatz logo

271 assets in Renal Cell Carcinoma

Therapeutic assets addressing Renal Cell Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Vsv-Ifnβ-Nis
Renal Cell Carcinoma
Vyriad, Inc.P1/2CC (45)
TIL
Renal Cell Carcinoma
City of Hope Medical CenterP1CC (44)
111in-xyimsr-01
Renal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP1CC (43)
18f-trx
Renal Cell Carcinoma
Rahul AggarwalP1CC (43)
Adagrasib
Renal Cell Carcinoma
Kura Oncology, Inc.P1CC (43)
Darlifarnib
Renal Cell Carcinoma
Kura Oncology, Inc.P1CC (43)
dff332
Renal Cell Carcinoma
Novartis PharmaceuticalsP1CC (43)
Jmkx003948
Renal Cell Carcinoma
JemincareP1CC (43)
kfa115
Renal Cell Carcinoma
Novartis PharmaceuticalsP1CC (43)
LXP1788
Renal Cell Carcinoma
LaunXP Biomedical Co., Ltd.P1CC (43)
mk-3795
Renal Cell Carcinoma
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)P1CC (43)
Myrciaria Dubia Prebiotic Supplement
Renal Cell Carcinoma
City of Hope Medical CenterP1CC (43)
pf-07263689
Renal Cell Carcinoma
PfizerP1CC (43)
qeq278
Renal Cell Carcinoma
Novartis PharmaceuticalsP1CC (43)
Spx-303
Renal Cell Carcinoma
SparX Biotech(Jiangsu) Co., Ltd.P1CC (43)
Valemetostat
Renal Cell Carcinoma
M.D. Anderson Cancer CenterP1CC (43)
zm008
Renal Cell Carcinoma
Zumutor Biologics Inc.P1CC (43)
Anti-Cd70-Car-T Cells
Renal Cell Carcinoma
Shanghai Changzheng HospitalP1CC (42)
cd70-targeting car-t cells
Renal Cell Carcinoma
Chongqing Precision Biotech Co., LtdP1CC (42)
Nogapendekin Alfa Inbakicept
Renal Cell Carcinoma
ImmunityBio, Inc.P2CC (42)
177Lu-TLX250
Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty LimitedP1CC (41)
a2b395
Renal Cell Carcinoma
A2 Biotherapeutics Inc.P1/2CC (41)
ab598
Renal Cell Carcinoma
Arcus Biosciences, Inc.P1CC (41)
Alintegimod
Renal Cell Carcinoma
7 Hills Pharma, LLCP1/2CC (41)
Anti-Human Cd70 T-Cell
Renal Cell Carcinoma
Hrain Biotechnology Co., Ltd.P1CC (41)
azd6750
Renal Cell Carcinoma
AstraZenecaP1/2CC (41)
Bgb-A445
Renal Cell Carcinoma
BeiGeneP1/2CC (41)
Ctx-10726
Renal Cell Carcinoma
Compass TherapeuticsP1CC (41)
Exemestane
Renal Cell Carcinoma
SAPU NANO (US) LLCP1CC (41)
Fermented Wheat Germ Extract
Renal Cell Carcinoma
University of California, DavisP1CC (41)
gen1160
Renal Cell Carcinoma
GenmabP1/2CC (41)
gm103
Renal Cell Carcinoma
GeneMedicine Co., Ltd.P1/2CC (41)
Hafnium Oxide
Renal Cell Carcinoma
NanobiotixP1CC (41)
her2bbζ/cd19t+ t cells
Renal Cell Carcinoma
Shanghai Public Health Clinical CenterP1/2CC (41)
Immunoglobulin G1 (134-Cysteine,228-Valine,242-Phenylalanine,243-Glutamic Acid,339-Serine,362-Cysteine,374-Tryptophan), Anti-(Human Cytotoxic T-Lymphocyte-Associated Protein 4) (Human Monoclonal Medi5752 .Gamma.1-Chain), Disulfide With (122-Cysteine,212-Valine) Human Monoclonal Medi5752 .Lambda.-Chain, (234->231')(237->234')(362->354') Tris(Disulfide) With Immunoglobulin G1 (239-Phenylalanine,240-Glutamic Acid,336-Serine,354-Cysteine,371-Serine,373-Alanine,412-Valine) Anti-(Human Programmed Cell Death Protein 1) (Human-Mus Musculus Monoclonal Medi5752 .Gamma.1-Chain) Disulfide With Human-Mus Musculus Monoclonal Medi5752 .Kappa.-Chain
Renal Cell Carcinoma
MedImmune LLCP1CC (41)
Inbrx-106
Renal Cell Carcinoma
Inhibrx Biosciences, IncP1/2CC (41)
Interleukin 18 (Recombinant Human Mutein Clone St-067)
Renal Cell Carcinoma
Simcha IL-18, Inc.P1/2CC (41)
neo212
Renal Cell Carcinoma
Neonc Technologies, Inc.P1/2CC (41)
ngm707
Renal Cell Carcinoma
NGM Biopharmaceuticals, IncP1/2CC (41)
nxp900
Renal Cell Carcinoma
Nuvectis Pharma, Inc.P1CC (41)
Oatd-02
Renal Cell Carcinoma
Molecure S.A.P1CC (41)
Pexmetinib
Renal Cell Carcinoma
Dan ZandbergP1/2CC (41)
Rilvegostomig
Renal Cell Carcinoma
AstraZenecaP1/2CC (41)
Ruxolitinib
Renal Cell Carcinoma
University of California, San DiegoP1/2CC (41)
Sapu003
Renal Cell Carcinoma
SAPU NANO (US) LLCP1CC (41)
Sitagliptin
Renal Cell Carcinoma
Fernando Maciel BarbosaP1CC (41)
Trastuzumab Deruxtecan
Renal Cell Carcinoma
AstraZenecaP1/2CC (41)
Ziv-Aflibercept
Renal Cell Carcinoma
National Cancer Institute (NCI)P1CC (41)
Cdx-585
Renal Cell Carcinoma
Celldex TherapeuticsP1CC (40)
Lorigerlimab
Renal Cell Carcinoma
MacroGenicsP1CC (40)
Showing 151 to 200 of 271 assets
PreviousPage 4 of 6Next